Skip to main content
OpenTrials
Completed

NCT Number: NCT05205876

Safety and Feasibility Study of the Eddii Mobile Application

The study is designed to measure the safety and feasibility of the Eddii mobile app for children living with Type-1 diabetes and using a CGM (Continuous Glucose monitor).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

5 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Eddii, inc.

New York, 10016, United States

About this study

Wearable continuous glucose monitoring (CGM) sensors have revolutionized diabetes management over the past decade. By providing blood glucose (BG) concentration measurements continuously over consecutive days, CGMs are an increasingly adopted technology. While CGM devices have been shown to improve the safety and effectiveness of diabetes therapy to reduce hypoglycemia incidents and durability and to decrease glycemic variability CGM software and tools available for users to feel motivated and engaged are limited. Users of CGM often use an app that provides an interface for them to track their BG. In most cases, this app is offered by their CGM device provider.

These interfaces are considerably basic and scientific in nature, often developed by scientists and engineers for the everyday user. These apps are particularly dull and tiresome for children and adolescents living with diabetes. Current real-time CGM interfaces present real-time BG reading, in addition to the BG trend and a historical chart, together with minimal options for the user to enter lifestyle data such as medications, meals, and exercise. Examples of such default interfaces are ones offered by Dexcom, Medtronic Guardian and Freestyle Libre. While some of these apps provide patterns and health summaries to the user, these are provided in a separate app to the one streaming real-time BG. With the emergence of rtAPI (real-time Application Programming Interface) integrations with CGMs, there is ample opportunity to improve the dynamism, sophistication, and offerings within these CGM Apps , creating a platform that delights the user rather than one that makes diabetes management seem like a daily chore. Furthermore, it is hypothesized that creating additional engagement in the form of games and real-life rewards will improve glycemic control.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(Pediatric Volunteers)

Subject must meet all of the following to be enrolled.

  • Volunteer, or their Authorized Representative, is willing and able to provide written informed consent, including authorization to release health information
  • Volunteer is > 5 years and < 12 years of age (inclusive) at time of consent
  • Volunteer has been diagnosed with Type 1 diabetes
  • Volunteer has been utilizing the Dexcom continuous glucose monitor for a minimum of 6 months prior to enrollment in the study
  • Volunteer must use the Dexcom mobile application
  • Volunteer has a parent or legal guardian willing to participate in the study
  • Volunteer must have access to and use an iOS smart phone, iPhone 10 model or above

Parent / Guardian Volunteers:

Subject must meet all of the following to be enrolled.

  • Volunteer is willing and able to provide written informed consent, including authorization to release health information
  • Volunteer has a child that meets study inclusion criteria and is willing to participate in the study
  • Volunteer lives with a child that meets study inclusion criteria and is willing to participate in the study
  • Volunteer is willing to be responsible for management of the Eddii mobile application use
  • Volunteer must have and use an iOS smart phone device

Exclusion criteria

  • EXCLUSION CRITERIA (Pediatric Volunteers)

Subject will be excluded if any of the below are present.

  • Volunteer is unwilling or unable to provide written informed consent and/or does not have an authorized representative who can provide consent on their behalf
  • Volunteer does not have access to an iOS smartphone device
  • Volunteer does not have access to the internet
  • Volunteer is enrolled in another research study at the time of enrollment

Exclusion criteria

(Parents / Guardians) Subject will be excluded if any of the below are present.

  • Volunteer is unwilling or unable to provide written informed consent and/or does not have an authorized representative who can provide consent on their behalf
  • Volunteer does not have access to an iOS smartphone device
  • Volunteer does not have access to the internet
  • Volunteer is enrolled in another research study at the time of enrollment

Treatment and study plan

Eddii mobile application

Behavioral

Participants will use the Eddii mobile application in the intervention arm.

Primary outcomes

  1. Safety of the Eddii App as assessed by accuracy and reliability of blood glucose measurements

    Time frame: Eight Weeks

    Safety (Intervention Arm only) as assessed by:

    ○ Functionality and reliability of Eddii application by measuring reported faults

  2. Feasibility of the Eddii App as measured by frequency of use

    Time frame: Four Weeks

    Feasibility (Intervention Arm only) as measured by:

    • App analytics to determine total number and frequency of logins from enrollment to Week 8
    • App analytics to determine application features are easily accessible, understandable and are used effectively

Secondary outcomes

  1. Change in glycaemic control measured as Time-in-Range (TIR) (70-180mg/dl)

    Time frame: Eight Weeks

  2. QOL (Quality of Life) metrics

    Time frame: Eight Weeks

    • QOL questionnaires conducted mid-study on weeks 2, 4, 6 and 8
  3. User Engagement measured through app analytics

    Time frame: Eight Weeks

    App-Specific Measures for Entirety of Study (Intervention Arm only)

    ○ Engagement and retention of users

Sponsors and collaborators

Lead sponsor

Eddii, Inc.

Industry

Registry information

Official study title

A Safety and Feasibility Study of the Eddii Mobile Application for Glucose Monitoring in Pediatric Patients With Type I Diabetes

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jan 25, 2022
Registry last updated
Oct 5, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.